Cold Genesys looks to China for a $10M cash infusion

Damian Garde

Immuno-oncology biotech raised a $ 10 million B round, rallying a stable of Chinese financiers as it moves forward with a late-stage cancer therapy.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS